Literature DB >> 8797050

Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C.

M Nakajima1, Y Kubota, N Miyashita, Y Niki, T Matsushima, T Manabe.   

Abstract

We report a 67-year-old male patient with a known history of sarcoidosis in remission who had recurrent sarcoidosis following a five-month administration of interferon alpha (IFN-alpha) for chronic hepatitis C. He developed bilateral swelling of the parotid glands and bilateral diffuse reticulonodular pulmonary parenchymal opacities on chest roentgenograms. Serum angiotensin converting enzyme (ACE) levels and soluble IL-2 receptor levels were high and a transbronchial lung biopsy revealed noncaseating granulomas. The abnormalities on both laboratory data and chest roentgenograms were resolved after administration of oral prednisolone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797050     DOI: 10.2169/internalmedicine.35.376

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

1.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

2.  Sarcoidosis-associated hepatitis C virus infection.

Authors:  F Bonnet; P Morlat; J Dubuc; S De Witte; M Bonarek; N Bernard; D Lacoste; J Beylot
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

Review 3.  Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature.

Authors:  V Tahan; F Ozseker; D Guneylioglu; A Baran; R Ozaras; A Mert; A C Ucisik; T Cagatay; D Yilmazbayhan; H Senturk
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

Review 4.  Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature.

Authors:  Ali Nawras; Mohammad M Alsolaiman; Shahid Mehboob; Catherine Bartholomew; Benedict Maliakkal
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

5.  Multisystem Sarcoidosis in a Patient on Interferon-α Therapy for Chronic Hepatitis C.

Authors:  Bouchra Oudghiri; Mohammed Benzagmout; Saïd Boujraf; Fawzi Belahcen; Adil Ibrahimi
Journal:  J Glob Infect Dis       Date:  2012-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.